Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2005 6
2006 7
2007 5
2008 1
2009 1
2010 1
2011 1
2014 2
2015 1
2017 4
2018 2
2020 2
2021 1
2022 1
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Results by year

Filters applied: . Clear all
Page 1
Safety and efficacy of continuous subcutaneous foslevodopa-foscarbidopa in patients with advanced Parkinson's disease: a randomised, double-blind, active-controlled, phase 3 trial.
Soileau MJ, Aldred J, Budur K, Fisseha N, Fung VS, Jeong A, Kimber TE, Klos K, Litvan I, O'Neill D, Robieson WZ, Spindler MA, Standaert DG, Talapala S, Vaou EO, Zheng H, Facheris MF, Hauser RA. Soileau MJ, et al. Among authors: budur k. Lancet Neurol. 2022 Dec;21(12):1099-1109. doi: 10.1016/S1474-4422(22)00400-8. Lancet Neurol. 2022. PMID: 36402160 Clinical Trial.
Continuous Subcutaneous Foslevodopa/Foscarbidopa in Parkinson's Disease: Safety and Efficacy Results From a 12-Month, Single-Arm, Open-Label, Phase 3 Study.
Aldred J, Freire-Alvarez E, Amelin AV, Antonini A, Bergmans B, Bergquist F, Bouchard M, Budur K, Carroll C, Chaudhuri KR, Criswell SR, Danielsen EH, Gandor F, Jia J, Kimber TE, Mochizuki H, Robieson WZ, Spiegel AM, Standaert DG, Talapala S, Facheris MF, Fung VSC. Aldred J, et al. Among authors: budur k. Neurol Ther. 2023 Dec;12(6):1937-1958. doi: 10.1007/s40120-023-00533-1. Epub 2023 Aug 26. Neurol Ther. 2023. PMID: 37632656 Free PMC article.
Pathological lying.
Adetunji B, Basil B, Budur K, Oladinni O. Adetunji B, et al. Among authors: budur k. J Am Acad Psychiatry Law. 2006;34(1):131-2; author reply 132-3. J Am Acad Psychiatry Law. 2006. PMID: 16585256 No abstract available.
Advances in treating insomnia.
Budur K, Rodriguez C, Foldvary-Schaefer N. Budur K, et al. Cleve Clin J Med. 2007 Apr;74(4):251-2, 255-8, 261-2 passim. doi: 10.3949/ccjm.74.4.251. Cleve Clin J Med. 2007. PMID: 17438674 Free article. Review.
Advancing combination therapy for Alzheimer's disease.
Salloway SP, Sevingy J, Budur K, Pederson JT, DeMattos RB, Von Rosenstiel P, Paez A, Evans R, Weber CJ, Hendrix JA, Worley S, Bain LJ, Carrillo MC. Salloway SP, et al. Among authors: budur k. Alzheimers Dement (N Y). 2020 Oct 7;6(1):e12073. doi: 10.1002/trc2.12073. eCollection 2020. Alzheimers Dement (N Y). 2020. PMID: 33043108 Free PMC article.
Measuring cognition and function in the preclinical stage of Alzheimer's disease.
Weintraub S, Carrillo MC, Farias ST, Goldberg TE, Hendrix JA, Jaeger J, Knopman DS, Langbaum JB, Park DC, Ropacki MT, Sikkes SAM, Welsh-Bohmer KA, Bain LJ, Brashear R, Budur K, Graf A, Martenyi F, Storck MS, Randolph C. Weintraub S, et al. Among authors: budur k. Alzheimers Dement (N Y). 2018 Feb 13;4:64-75. doi: 10.1016/j.trci.2018.01.003. eCollection 2018. Alzheimers Dement (N Y). 2018. PMID: 29955653 Free PMC article. Review.
Couvade syndrome equivalent?
Budur K, Mathews M, Mathews M. Budur K, et al. Psychosomatics. 2005 Jan-Feb;46(1):71-2. doi: 10.1176/appi.psy.46.1.71. Psychosomatics. 2005. PMID: 15765824 No abstract available.
The CATIE study.
Basil B, Mathews M, Adetunji B, Budur K. Basil B, et al. Among authors: budur k. Am J Psychiatry. 2006 Mar;163(3):555; author reply 555-6. doi: 10.1176/appi.ajp.163.3.555. Am J Psychiatry. 2006. PMID: 16513895 No abstract available.
37 results